Advertisement

Intrauterine Growth Restriction, Small for Gestational Age, and Experimental Obesity

  • Michael G. Ross
  • Ivan Huber
  • Mina Desai
Chapter
Part of the Endocrine Updates book series (ENDO, volume 30)

Abstract

Both high and low birth weight (LBW) have a programmed predisposition to adult metabolic syndrome, which is exacerbated by exposure to Western high-fat diets. This review discusses animal models of obesity, including programming during embryonic, fetal, and postnatal periods. Programming affects a diversity of organ systems, but we focus specifically on central appetite function and peripheral adipogenesis/lipogenesis. Appetite is regulated by hypothalamic orexigenic and anorexigenic pathways, the neurons of which receive central (e.g., synaptic) and peripheral (e.g., leptin, ghrelin, insulin) input which adjust orexigenic drive. In humans, appetite pathways are well developed while satiety circuits are notably less functional, contributing to the difficulty of self-motivated dietary weight loss. The analysis of neural stem cell cultures (NSCs) has provided an insight into how leptin and insulin deficiency, associated with LBW, may permanently affect development of hypothalamic appetite pathways and thus program ingestive behavior. In regards to programmed adiposity, we review the pivotal role of the adipogenic transcription factor PPARγ, which promotes both adipogenesis and lipogenesis, contributing to the development of obesity. Neonatal leptin supplementation may prevent programmed obesity in animal models of LBW. Although this hormone may be considered as an additive for LBW humans, additional studies are needed prior to clinical intervention. Further research is needed for approaches to the optimization of fetal growth throughout pregnancy. In the interim, maternal breastfeeding of LBW and normal weight newborns should be encouraged.

Keywords

Hypothalamic programming Metabolic syndrome Appetite Satiety Adipogenesis Lipogenesis 

References

  1. 1.
    Barker DJ, Bagby SP, Hanson MA. Mechanisms of disease: in utero programming in the pathogenesis of hypertension. Nat Clin Pract Nephrol. 2006;2(12):700–7.PubMedCrossRefGoogle Scholar
  2. 2.
    Barker DJ. Fetal programming of coronary heart disease. Trends Endocrinol Metab. 2002;13(9):364–8.PubMedCrossRefGoogle Scholar
  3. 3.
    Godfrey KM, Barker DJ. Fetal programming and adult health. Public Health Nutr. 2001;4(2B):611–24.PubMedCrossRefGoogle Scholar
  4. 4.
    Nilsson PM, Ostergren PO, Nyberg P, Soderstrom M, Allebeck P. Low birth weight is associated with elevated systolic blood pressure in adolescence: a prospective study of a birth cohort of 149378 Swedish boys. J Hypertens. 1997;15(12 Pt 2):1627–31.PubMedCrossRefGoogle Scholar
  5. 5.
    Ozanne SE, Hales CN. Early programming of glucose-insulin metabolism. Trends Endocrinol Metab. 2002;13(9):368–73.PubMedCrossRefGoogle Scholar
  6. 6.
    Barker DJ, Eriksson JG, Forsen T, Osmond C. Fetal origins of adult disease: strength of effects and biological basis. Int J Epidemiol. 2002;31(6):1235–9.PubMedCrossRefGoogle Scholar
  7. 7.
    Yajnik CS. Early life origins of insulin resistance and type 2 diabetes in India and other Asian countries. J Nutr. 2004;134(1):205–10.PubMedGoogle Scholar
  8. 8.
    Desai M, Hales CN. Role of fetal and infant growth in programming metabolism in later life. Biol Rev Camb Philos Soc. 1997;72(2):329–48.PubMedCrossRefGoogle Scholar
  9. 9.
    Hales CN, Barker DJ. The thrifty phenotype hypothesis. Br Med Bull. 2001;60:5–20.PubMedCrossRefGoogle Scholar
  10. 10.
    Ross MG, Desai M. Gestational programming: population survival effects of drought and famine during pregnancy. Am J Physiol Regul Integr Comp Physiol. 2005;288(1):R25–R33.PubMedCrossRefGoogle Scholar
  11. 11.
    Barker DJ. Intrauterine programming of adult disease. Mol Med Today. 1995;1(9):418–23.PubMedCrossRefGoogle Scholar
  12. 12.
    Desai M, Crowther NJ, Ozanne SE, Lucas A, Hales CN. Adult glucose and lipid metabolism may be programmed during fetal life. Biochem Soc Trans. 1995;23(2):331–5.PubMedGoogle Scholar
  13. 13.
    Lucas A, Baker BA, Desai M, Hales CN. Nutrition in pregnant or lactating rats programs lipid metabolism in the offspring. Br J Nutr. 1996;76(4):605–12.PubMedCrossRefGoogle Scholar
  14. 14.
    Barker M, Robinson S, Osmond C, Barker DJ. Birth weight and body fat distribution in adolescent girls. Arch Dis Child. 1997;77(5):381–3.PubMedCrossRefGoogle Scholar
  15. 15.
    Jones AP, Simson EL, Friedman MI. Gestational undernutrition and the development of obesity in rats. J Nutr. 1984;114(8):1484–92.PubMedGoogle Scholar
  16. 16.
    Ravelli GP, Stein ZA, Susser MW. Obesity in young men after famine exposure in utero and early infancy. N Engl J Med. 1976;295(7):349–53.PubMedCrossRefGoogle Scholar
  17. 17.
    Vickers MH, Breier BH, Cutfield WS, Hofman PL, Gluckman PD. Fetal origins of hyperphagia, obesity, and hypertension and postnatal amplification by hypercaloric nutrition. Am J Physiol Endocrinol Metab. 2000;279(1):E83–7.PubMedGoogle Scholar
  18. 18.
    Levin BE, Govek E. Gestational obesity accentuates obesity in obesity-prone progeny. Am J Physiol. 1998;275(4 Pt 2):R1374–9.PubMedGoogle Scholar
  19. 19.
    Faust IM, Johnson PR, Hirsch J. Long-term effects of early nutritional experience on the development of obesity in the rat. J Nutr. 1980;110(10):2027–34.PubMedGoogle Scholar
  20. 20.
    Gillman MW, Rifas-Shiman SL, Camargo CA Jr., Berkey CS, Frazier AL, Rockett HR, et al. Risk of overweight among adolescents who were breastfed as infants. JAMA. 2001;285(19):2461–7.PubMedCrossRefGoogle Scholar
  21. 21.
    Barker DJ. In utero programming of chronic disease. Clin Sci (Lond). 1998;95(2):115–28.CrossRefGoogle Scholar
  22. 22.
    Barker DJ. Intrauterine programming of adult disease. Mol Med Today. 1995;1(9):418–23.PubMedCrossRefGoogle Scholar
  23. 23.
    Phillips DI, Barker DJ, Osmond C. Infant feeding, fetal growth and adult thyroid function. Acta Endocrinol (Copenh). 1993;129(2):134–8.Google Scholar
  24. 24.
    Dodic M, May CN, Wintour EM, Coghlan JP. An early prenatal exposure to excess glucocorticoid leads to hypertensive offspring in sheep. Clin Sci (Lond). 1998;94(2):149–55.Google Scholar
  25. 25.
    McMillen IC, Robinson JS. Developmental origins of the metabolic syndrome: prediction, plasticity, and programming. Physiol Rev. 2005;85(2):571–633.PubMedCrossRefGoogle Scholar
  26. 26.
    Perseghin G, Ghosh S, Gerow K, Shulman GI. Metabolic defects in lean nondiabetic offspring of NIDDM parents: a cross-sectional study. Diabetes. 1997;46(6):1001–9.PubMedCrossRefGoogle Scholar
  27. 27.
    Desai M, Gayle D, Babu J, Ross MG. Programmed obesity in intrauterine growth-restricted newborns: modulation by newborn nutrition. Am J Physiol Regul Integr Comp Physiol. 2005;288(1):R91–6.PubMedCrossRefGoogle Scholar
  28. 28.
    Remacle C, Bieswal F, Reusens B. Programming of obesity and cardiovascular disease. Int J Obes Relat Metab Disord. 2004;28 Suppl 3:S46–S53.PubMedCrossRefGoogle Scholar
  29. 29.
    Andrew R, Phillips DI, Walker BR. Obesity and gender influence cortisol secretion and metabolism in man. J Clin Endocrinol Metab. 1998;83(5):1806–9.PubMedCrossRefGoogle Scholar
  30. 30.
    Ong KK, Ahmed ML, Emmett PM, Preece MA, Dunger DB. Association between postnatal catch-up growth and obesity in childhood: prospective cohort study. BMJ. 2000;320(7240):967–71.PubMedCrossRefGoogle Scholar
  31. 31.
    Rogers I. The influence of birthweight and intrauterine environment on adiposity and fat distribution in later life. Int J Obes Relat Metab Disord. 2003;27(7):755–77.PubMedCrossRefGoogle Scholar
  32. 32.
    Yajnik C. Interactions of perturbations in intrauterine growth and growth during childhood on the risk of adult-onset disease. Proc Nutr Soc. 2000;59(2):257–65.PubMedCrossRefGoogle Scholar
  33. 33.
    Stocker CJ, Arch JR, Cawthorne MA. Fetal origins of insulin resistance and obesity. Proc Nutr Soc. 2005;64(2):143–51.PubMedCrossRefGoogle Scholar
  34. 34.
    Jaquet D, Deghmoun S, Chevenne D, Collin D, Czernichow P, Levy-Marchal C. Dynamic change in adiposity from fetal to postnatal life is involved in the metabolic syndrome associated with reduced fetal growth. Diabetologia. 2005;48(5):849–55.PubMedCrossRefGoogle Scholar
  35. 35.
    Vanhala M. Childhood weight and metabolic syndrome in adults. Ann Med. 1999;31(4):236–9.PubMedCrossRefGoogle Scholar
  36. 36.
    Widdowson EM, McCance RA. A review: new thoughts on growth. Pediatr Res. 1975;9(3):154–6.PubMedCrossRefGoogle Scholar
  37. 37.
    McCance RA, Widdowson EM. The effect of undernutrition upon the composition of the body and its tissues. Acta Med Scand. 1953;146(1):45–6.PubMedCrossRefGoogle Scholar
  38. 38.
    Widdowson EM, McCance RA. The effect of finite periods of undernutrition at different ages on the composition and subsequent development of the rat. Proc R Soc Lond B Biol Sci. 1963;158:329–42.PubMedCrossRefGoogle Scholar
  39. 39.
    Widdowson EM, McCance RA. Some effects of accelerating growth. I. General somatic development. Proc R Soc Lond B Biol Sci. 1960;152:188–206.PubMedCrossRefGoogle Scholar
  40. 40.
    Gluckman PD, Cutfield W, Hofman P, Hanson MA. The fetal, neonatal, and infant environments-the long-term consequences for disease risk. Early Hum Dev. 2005;81(1):51–9.PubMedCrossRefGoogle Scholar
  41. 41.
    Horton TH. Fetal origins of developmental plasticity: animal models of induced life history variation. Am J Hum Biol. 2005;17(1):34–43.PubMedCrossRefGoogle Scholar
  42. 42.
    Winick M. Cellular growth in intrauterine malnutrition. Pediatr Clin North Am. 1970;17(1):69–78.PubMedGoogle Scholar
  43. 43.
    Winick M, Rosso P, Brasel JA. Malnutrition and cellular growth in the brain: existence of critical periods. In: lipids, malnutrition and the developing brain. Ciba Found Symp. 1971;199–212.Google Scholar
  44. 44.
    Winick M, Noble A. Cellular response in rats during malnutrition at various ages. J Nutr. 1966;89(3):300–6.PubMedGoogle Scholar
  45. 45.
    Winick M, Noble A. Cellular response with increased feeding in neonatal rats. J Nutr. 1967;91(2):179–82.PubMedGoogle Scholar
  46. 46.
    Winick M, Noble A. Quantitative changes in DNA, RNA, and protein during prenatal and postnatal growth in the rat. Dev Biol. 1965;12(3):451–66.PubMedCrossRefGoogle Scholar
  47. 47.
    Desai M, Crowther NJ, Lucas A, Hales CN. Organ-selective growth in the offspring of protein-restricted mothers. Br J Nutr. 1996;76(4):591–603.PubMedCrossRefGoogle Scholar
  48. 48.
    Desai M, Gayle D, Babu J, Ross MG. Permanent reduction in heart and kidney organ growth in offspring of undernourished rat dams. Am J Obstet Gynecol. 2005;193 3 Suppl:1224–32.PubMedCrossRefGoogle Scholar
  49. 49.
    Vuguin PM. Animal models for small for gestational age and fetal programming of adult disease. Horm Res. 2007;68(3):113–23.PubMedCrossRefGoogle Scholar
  50. 50.
    Gluckman PD, Hanson MA, Spencer HG. Predictive adaptive responses and human evolution. Trends Ecol Evol. 2005;20(10):527–33.PubMedCrossRefGoogle Scholar
  51. 51.
    Toste FP, de Moura EG, Lisboa PC, Fagundes AT, de OE, Passos MC. Neonatal leptin treatment programmes leptin hypothalamic resistance and intermediary metabolic parameters in adult rats. Br J Nutr. 2006;95(4):830–7.PubMedCrossRefGoogle Scholar
  52. 52.
    Desai M, Gayle D, Babu J, Ross MG. The timing of nutrient restriction during rat pregnancy/lactation alters metabolic syndrome phenotype. Am J Obstet Gynecol. 2007;196(6):555–7.PubMedCrossRefGoogle Scholar
  53. 53.
    Ozanne SE. Metabolic programming in animals. Br Med Bull. 2001;60:143–52.PubMedCrossRefGoogle Scholar
  54. 54.
    Ozanne SE, Hales CN. The long-term consequences of intra-uterine protein malnutrition for glucose metabolism. Proc Nutr Soc. 1999;58(3):615–9.PubMedCrossRefGoogle Scholar
  55. 55.
    Swenne I, Crace CJ, Milner RD. Persistent impairment of insulin secretory response to glucose in adult rats after limited period of protein-calorie malnutrition early in life. Diabetes. 1987;36(4):454–8.PubMedCrossRefGoogle Scholar
  56. 56.
    Woodall SM, Johnston BM, Breier BH, Gluckman PD. Chronic maternal undernutrition in the rat leads to delayed postnatal growth and elevated blood pressure of offspring. Pediatr Res. 1996;40(3):438–43.PubMedCrossRefGoogle Scholar
  57. 57.
    Shepard TH, Mackler B, Finch CA. Reproductive studies in the iron-deficient rat. Teratology. 1980;22(3):329–34.PubMedCrossRefGoogle Scholar
  58. 58.
    Felt BT, Lozoff B. Brain iron and behavior of rats are not normalized by treatment of iron deficiency anemia during early development. J Nutr. 1996;126(3):693–701.PubMedGoogle Scholar
  59. 59.
    Reinisch JM, Simon NG, Karow WG, Gandelman R. Prenatal exposure to prednisone in humans and animals retards intrauterine growth. Science. 1978;202(4366):436–8.PubMedCrossRefGoogle Scholar
  60. 60.
    Seckl. JR. Glucocorticoids, 11b-hydroxysteroid [beta] dehydrogenase and fetal programming. In: O’Brien PMS, Wheeler T, Barker DJP, editors. Fetal programming. Influences on development and disease in later life. London: Royal College of Obstetricians and Gynaecologists; 1999. pp. 430–9.Google Scholar
  61. 61.
    Wigglesworth JS. Fetal growth retardation. Animal model: uterine vessel ligation in the pregnant rat. Am J Pathol. 1974;77(2):347–50.PubMedGoogle Scholar
  62. 62.
    Simmons RA, Templeton LJ, Gertz SJ. Intrauterine growth retardation leads to the development of type 2 diabetes in the rat. Diabetes. 2001;50(10):2279–86.PubMedCrossRefGoogle Scholar
  63. 63.
    Camprubi M, Ortega A, Balaguer A, Iglesias I, Girabent M, Callejo J, et al. Cauterization of meso-ovarian vessels, a new model of intrauterine growth restriction in rats. Placenta. 2009;30(9):761–6.PubMedCrossRefGoogle Scholar
  64. 64.
    Morrison JL. Sheep models of intrauterine growth restriction: fetal adaptations and consequences. Clin Exp Pharmacol Physiol. 2008;35(7):730–43.PubMedCrossRefGoogle Scholar
  65. 65.
    Anthony RV, Scheaffer AN, Wright CD, Regnault TR. Ruminant models of prenatal growth restriction. Reprod Suppl. 2003;61:183–94.PubMedGoogle Scholar
  66. 66.
    Luque A, Carpizo DR, Iruela-Arispe ML. ADAMTS1/METH1 inhibits endothelial cell proliferation by direct binding and sequestration of VEGF165. J Biol Chem. 2003;278(26):23656–65.PubMedCrossRefGoogle Scholar
  67. 67.
    Wallace JM, Regnault TR, Limesand SW, Hay WW Jr., Anthony RV. Investigating the causes of low birth weight in contrasting ovine paradigms. J Physiol. 2005;565(Pt 1):19–26.PubMedCrossRefGoogle Scholar
  68. 68.
    Barry JS, Anthony RV. The pregnant sheep as a model for human pregnancy. Theriogenology. 2008;69(1):55–67.PubMedCrossRefGoogle Scholar
  69. 69.
    Wallace JM, Aitken RP, Milne JS, Hay WW Jr. Nutritionally mediated placental growth restriction in the growing adolescent: consequences for the fetus. Biol Reprod. 2004;71(4):1055–62.PubMedCrossRefGoogle Scholar
  70. 70.
    Nielsen JN, O’Brien KO, Witter FR, Chang SC, Mancini J, Nathanson MS, et al. High gestational weight gain does not improve birth weight in a cohort of African American adolescents. Am J Clin Nutr. 2006;84(1):183–9.PubMedGoogle Scholar
  71. 71.
    Ross MG, Desai M, Khorram O, McKnight RA, Lane RH, Torday J. Gestational programming of offspring obesity: a potential contributor to Alzheimer’s disease. Curr Alzheimer Res. 2007;4(2):213–7.PubMedCrossRefGoogle Scholar
  72. 72.
    Crossey PA, Pillai CC, Miell JP. Altered placental development and intrauterine growth restriction in IGF binding protein-1 transgenic mice. J Clin Invest. 2002;110(3):411–8.PubMedGoogle Scholar
  73. 73.
    Coe BL, Kirkpatrick JR, Taylor JA, vom Saal FS. A new ‘crowded uterine horn’ mouse model for examining the relationship between foetal growth and adult obesity. Basic Clin Pharmacol Toxicol. 2008;102(2):162–7.PubMedCrossRefGoogle Scholar
  74. 74.
    Tumbleson M. Swine in biomedical research. New York, NY: Plenum Press; 1986.Google Scholar
  75. 75.
    Baker DH. Animal models in nutrition research. J Nutr. 2008;138(2):391–6.PubMedGoogle Scholar
  76. 76.
    Stahl CH, Lei X, Larson B. Introduction to the symposium: appropriate animal models for nutritional research in health and disease. J Nutr. 2008;138(2):389–390.PubMedGoogle Scholar
  77. 77.
    Ireland JJ, Roberts RM, Palmer GH, Bauman DE, Bazer FW. A commentary on domestic animals as dual-purpose models that benefit agricultural and biomedical research. J Anim Sci. 2008;86(10):2797–805.PubMedCrossRefGoogle Scholar
  78. 78.
    Brambilla G, Cantafora A. Metabolic and cardiovascular disorders in highly inbred lines for intensive pig farming: how animal welfare evaluation could improve the basic knowledge of human obesity. Ann Ist Super Sanita. 2004;40(2):241–4.PubMedGoogle Scholar
  79. 79.
    Spurlock ME, Gabler NK. The development of porcine models of obesity and the metabolic syndrome. J Nutr. 2008;138(2):397–402.PubMedGoogle Scholar
  80. 80.
    Brisbin IL Jr., Mayer JJ. Problem pigs in a poke: a good pool of data. Science. 2001;294(5545):1280–1.PubMedCrossRefGoogle Scholar
  81. 81.
    Unterberger A, Szyf M, Nathanielsz PW, Cox LA. Organ and gestational age effects of maternal nutrient restriction on global methylation in fetal baboons. J Med Primatol. 2009;38(4):219–27.PubMedCrossRefGoogle Scholar
  82. 82.
    Ross MG, Beall MH. Adult sequelae of intrauterine growth restriction. Semin Perinatol. 2008;32(3):213–8.PubMedCrossRefGoogle Scholar
  83. 83.
    Arora S, Anubhuti. Role of neuropeptides in appetite regulation and obesity – a review. Neuropeptides. 2006;40:375–401.PubMedCrossRefGoogle Scholar
  84. 84.
    Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM. Positional cloning of the mouse obese gene and its human homologue. Nature. 1994;372(6505):425–32.PubMedCrossRefGoogle Scholar
  85. 85.
    Oliver P, Pico C, De Matteis R, Cinti S, Palou A. Perinatal expression of leptin in rat stomach. Dev Dyn. 2002;223(1):148–54.PubMedCrossRefGoogle Scholar
  86. 86.
    Cinti S, Matteis RD, Pico C, Ceresi E, Obrador A, Maffeis C, et al. Secretory granules of endocrine and chief cells of human stomach mucosa contain leptin. Int J Obes Relat Metab Disord. 2000;24(6):789–93.PubMedCrossRefGoogle Scholar
  87. 87.
    Hoggard N, Hunter L, Duncan JS, Williams LM, Trayhurn P, Mercer JG. Leptin and leptin receptor mRNA and protein expression in the murine fetus and placenta. Proc Natl Acad Sci USA. 1997;94(20):11073–8.PubMedCrossRefGoogle Scholar
  88. 88.
    Masuzaki H, Ogawa Y, Sagawa N, Hosoda K, Matsumoto T, Mise H, et al. Nonadipose tissue production of leptin: leptin as a novel placenta-derived hormone in humans. Nat Med. 1997;3(9):1029–33.PubMedCrossRefGoogle Scholar
  89. 89.
    Pich EM, Messori B, Zoli M, Ferraguti F, Marrama P, Biagini G, et al. Feeding and drinking responses to neuropeptide Y injections in the paraventricular hypothalamic nucleus of aged rats. Brain Res. 1992;575(2):265–71.PubMedCrossRefGoogle Scholar
  90. 90.
    Morley JE, Levine AS, Gosnell BA, Kneip J, Grace M. Effect of neuropeptide Y on ingestive behaviors in the rat. Am J Physiol. 1987;252(3 Pt 2):R599–R609.PubMedGoogle Scholar
  91. 91.
    Stanley BG, Leibowitz SF. Neuropeptide Y injected in the paraventricular hypothalamus: a powerful stimulant of feeding behavior. Proc Natl Acad Sci USA. 1985;82(11):3940–3.PubMedCrossRefGoogle Scholar
  92. 92.
    Stanley BG, Chin AS, Leibowitz SF. Feeding and drinking elicited by central injection of neuropeptide Y: evidence for a hypothalamic site(s) of action. Brain Res Bull. 1985;14(6):521–4.PubMedCrossRefGoogle Scholar
  93. 93.
    Stanley BG, Leibowitz SF, Neuropeptide Y. stimulation of feeding and drinking by injection into the paraventricular nucleus. Life Sci. 1984;35(26):2635–42.PubMedCrossRefGoogle Scholar
  94. 94.
    Yokosuka M, Kalra PS, Kalra SP. Inhibition of neuropeptide Y (NPY)-induced feeding and c-Fos response in magnocellular paraventricular nucleus by a NPY receptor antagonist: a site of NPY action. Endocrinology. 1999;140(10):4494–500.PubMedCrossRefGoogle Scholar
  95. 95.
    Vinuela MC, Larsen PJ. Identification of NPY-induced c-Fos expression in hypothalamic neurones projecting to the dorsal vagal complex and the lower thoracic spinal cord. J Comp Neurol. 2001;438(3):286–99.PubMedCrossRefGoogle Scholar
  96. 96.
    Yokosuka M, Dube MG, Kalra PS, Kalra SP. The mPVN mediates blockade of NPY-induced feeding by a Y5 receptor antagonist: a c-FOS analysis. Peptides. 2001;22(3):507–14.PubMedCrossRefGoogle Scholar
  97. 97.
    Niimi M, Sato M, Taminato T. Neuropeptide Y in central control of feeding and interactions with orexin and leptin. Endocrine. 2001;14(2):269–73.PubMedCrossRefGoogle Scholar
  98. 98.
    Yokosuka M, Xu B, Pu S, Kalra PS, Kalra SP. Neural substrates for leptin and neuropeptide Y (NPY) interaction: hypothalamic sites associated with inhibition of NPY-induced food intake. Physiol Behav. 1998;64(3):331–8.PubMedCrossRefGoogle Scholar
  99. 99.
    Xu B, Li BH, Rowland NE, Kalra SP. Neuropeptide Y injection into the fourth cerebroventricle stimulates c-Fos expression in the paraventricular nucleus and other nuclei in the forebrain: effect of food consumption. Brain Res. 1995;698(1–2):227–31.PubMedCrossRefGoogle Scholar
  100. 100.
    Lambert PD, Phillips PJ, Wilding JP, Bloom SR, Herbert J. c-fos expression in the paraventricular nucleus of the hypothalamus following intracerebroventricular infusions of neuropeptide Y. Brain Res. 1995;670(1):59–65.PubMedCrossRefGoogle Scholar
  101. 101.
    Li BH, Xu B, Rowland NE, Kalra SP. c-fos expression in the rat brain following central administration of neuropeptide Y and effects of food consumption. Brain Res. 1994;665(2):277–84.PubMedCrossRefGoogle Scholar
  102. 102.
    Pinto S, Roseberry AG, Liu H, Diano S, Shanabrough M, Cai X, et al. Rapid rewiring of arcuate nucleus feeding circuits by leptin. Science. 2004;304(5667):110–5.PubMedCrossRefGoogle Scholar
  103. 103.
    Takahashi KA, Cone RD. Fasting induces a large, leptin-dependent increase in the intrinsic action potential frequency of orexigenic arcuate nucleus neuropeptide Y/Agouti-related protein neurons. Endocrinology. 2005;146(3):1043–7.PubMedCrossRefGoogle Scholar
  104. 104.
    Ahima RS, Prabakaran D, Flier JS. Postnatal leptin surge and regulation of circadian rhythm of leptin by feeding. Implications for energy homeostasis and neuroendocrine function. J Clin Invest. 1998;101(5):1020–7.PubMedCrossRefGoogle Scholar
  105. 105.
    Bouret SG, Simerly RB. Developmental programming of hypothalamic feeding circuits. Clin Genet. 2006;70(4):295–301.PubMedCrossRefGoogle Scholar
  106. 106.
    Herrera E, Lasuncion MA, Huerta L, Martin-Hidalgo A. Plasma leptin levels in rat mother and offspring during pregnancy and lactation. Biol Neonate. 2000;78(4):315–20.PubMedCrossRefGoogle Scholar
  107. 107.
    Wirth JB, Epstein AN. Ontogeny of thirst in the infant rat. Am J Physiol. 1976;230(1):188–98.PubMedGoogle Scholar
  108. 108.
    Davidowa H, Plagemann A. Decreased inhibition by leptin of hypothalamic arcuate neurons in neonatally overfed young rats. Neuroreport. 2000;11(12):2795–8.PubMedCrossRefGoogle Scholar
  109. 109.
    Singer LK, Kuper J, Brogan RS, Smith MS, Grove KL. Novel expression of hypothalamic neuropeptide Y during postnatal development in the rat. Neuroreport. 2000;11(5):1075–80.PubMedCrossRefGoogle Scholar
  110. 110.
    Varma A, He J, Weissfeld L, Devaskar SU. Postnatal intracerebroventricular exposure to neuropeptide Y causes weight loss in female adult rats. Am J Physiol Regul Integr Comp Physiol. 2003;284(6):R1560–6.PubMedGoogle Scholar
  111. 111.
    Lin J, Richard BC, Kraeling RR, Rampacek GB. Developmental changes in the long form leptin receptor and related neuropeptide gene expression in the pig brain. Biol Reprod. 2001;64(6):1614–8.PubMedCrossRefGoogle Scholar
  112. 112.
    Matsuda J, Yokota I, Tsuruo Y, Murakami T, Ishimura K, Shima K, et al. Development changes in long-form leptin receptor expression and localization in rat brain. Endocrinology. 1999;140(11):5233–8.PubMedCrossRefGoogle Scholar
  113. 113.
    Proulx K, Richard D, Walker CD. Leptin regulates appetite-related neuropeptides in the hypothalamus of developing rats without affecting food intake. Endocrinology. 2002;143(12):4683–92.PubMedCrossRefGoogle Scholar
  114. 114.
    Mistry AM, Swick A, Romsos DR. Leptin alters metabolic rates before acquisition of its anorectic effect in developing neonatal mice. Am J Physiol. 1999;277(3 Pt 2):R742–7.PubMedGoogle Scholar
  115. 115.
    Howe DC, Gertler A, Challis JR. The late gestation increase in circulating ACTH and cortisol in the fetal sheep is suppressed by intracerebroventricular infusion of recombinant ovine leptin. J Endocrinol. 2002;174(2):259–66.PubMedCrossRefGoogle Scholar
  116. 116.
    Yuen BS, McMillen IC, Symonds ME, Owens PC. Abundance of leptin mRNA in fetal adipose tissue is related to fetal body weight. J Endocrinol. 1999;163(3):R11–4.PubMedCrossRefGoogle Scholar
  117. 117.
    Anguita RM, Sigulem DM, Sawaya AL. Intrauterine food restriction is associated with obesity in young rats. J Nutr. 1993;123(8):1421–8.PubMedGoogle Scholar
  118. 118.
    Plagemann A, Heidrich I, Gotz F, Rohde W, Dorner G. Obesity and enhanced diabetes and cardiovascular risk in adult rats due to early postnatal overfeeding. Exp Clin Endocrinol. 1992;99(3):154–8.PubMedCrossRefGoogle Scholar
  119. 119.
    Plagemann A, Harder T, Rake A, Voits M, Fink H, Rohde W, et al. Perinatal elevation of hypothalamic insulin, acquired malformation of hypothalamic galaninergic neurons, and syndrome x-like alterations in adulthood of neonatally overfed rats. Brain Res. 1999;836(1–2):146–55.PubMedCrossRefGoogle Scholar
  120. 120.
    Plagemann A, Harder T, Rake A, Waas T, Melchior K, Ziska T, et al. Observations on the orexigenic hypothalamic neuropeptide Y-system in neonatally overfed weanling rats. J Neuroendocrinol. 1999;11(7):541–6.PubMedCrossRefGoogle Scholar
  121. 121.
    Heidel E, Plagemann A, Davidowa H. Increased response to NPY of hypothalamic VMN neurons in postnatally overfed juvenile rats. Neuroreport. 1999;10(9):1827–31.PubMedCrossRefGoogle Scholar
  122. 122.
    Davidowa H, Li Y, Plagemann A. Altered neuronal responses to feeding-relevant peptides as sign of developmental plasticity in the hypothalamic regulatory system of body weight. Zh Vyssh Nerv Deiat Im I P Pavlova. 2003;53(5):663–70.PubMedGoogle Scholar
  123. 123.
    Davidowa H, Plagemann A. Different responses of ventromedial hypothalamic neurons to leptin in normal and early postnatally overfed rats. Neurosci Lett. 2000;293(1):21–4.PubMedCrossRefGoogle Scholar
  124. 124.
    Schmidt I, Schoelch C, Ziska T, Schneider D, Simon E, Plagemann A. Interaction of genetic and environmental programming of the leptin system and of obesity disposition. Physiol Genomics. 2000;3(2):113–20.PubMedGoogle Scholar
  125. 125.
    Davidowa H, Li Y, Plagemann A. Altered responses to orexigenic (AGRP, MCH) and anorexigenic (alpha-MSH, CART) neuropeptides of paraventricular hypothalamic neurons in early postnatally overfed rats. Eur J Neurosci. 2003;18(3):613–21.PubMedCrossRefGoogle Scholar
  126. 126.
    Davidowa H, Li Y, Plagemann A. Differential response to NPY of PVH and dopamine-responsive VMH neurons in overweight rats. Neuroreport. 2002;13(12):1523–7.PubMedCrossRefGoogle Scholar
  127. 127.
    Jones AP, Friedman MI. Obesity and adipocyte abnormalities in offspring of rats undernourished during pregnancy. Science. 1982;215(4539):1518–9.PubMedCrossRefGoogle Scholar
  128. 128.
    Geary M, Pringle PJ, Persaud M, Wilshin J, Hindmarsh PC, Rodeck CH, et al. Leptin concentrations in maternal serum and cord blood: relationship to maternal anthropometry and fetal growth. Br J Obstet Gynaecol. 1999;106(10):1054–60.PubMedCrossRefGoogle Scholar
  129. 129.
    Hoggard N, Haggarty P, Thomas L, Lea RG. Leptin expression in placental and fetal tissues: does leptin have a functional role? Biochem Soc Trans. 2001;29(Pt 2):57–63.PubMedCrossRefGoogle Scholar
  130. 130.
    Blum JW, Zbinden Y, Hammon HM, Chilliard Y. Plasma leptin status in young calves: effects of pre-term birth, age, glucocorticoid status, suckling, and feeding with an automatic feeder or by bucket. Domest Anim Endocrinol. 2005;28(2):119–33.PubMedCrossRefGoogle Scholar
  131. 131.
    Kotani Y, Yokota I, Kitamura S, Matsuda J, Naito E, Kuroda Y. Plasma adiponectin levels in newborns are higher than those in adults and positively correlated with birth weight. Clin Endocrinol (Oxf). 2004;61(4):418–23.CrossRefGoogle Scholar
  132. 132.
    McMillen IC, Muhlhausler BS, Duffield JA, Yuen BS. Prenatal programming of postnatal obesity: fetal nutrition and the regulation of leptin synthesis and secretion before birth. Proc Nutr Soc. 2004;63(3):405–12.PubMedCrossRefGoogle Scholar
  133. 133.
    Eckert JE, Gatford KL, Luxford BG, Campbell RG, Owens PC. Leptin expression in offspring is programmed by nutrition in pregnancy. J Endocrinol. 2000;165(3):R1–6.CrossRefGoogle Scholar
  134. 134.
    Warnes KE, Morris MJ, Symonds ME, Phillips ID, Clarke IJ, Owens JA, et al. Effects of increasing gestation, cortisol and maternal undernutrition on hypothalamic neuropeptide Y expression in the sheep fetus. J Neuroendocrinol. 1998;10(1):51–7.PubMedCrossRefGoogle Scholar
  135. 135.
    Plagemann A, Waas T, Harder T, Rittel F, Ziska T, Rohde W. Hypothalamic neuropeptide Y levels in weaning offspring of low-protein malnourished mother rats. Neuropeptides. 2000;34(1):1–6.PubMedCrossRefGoogle Scholar
  136. 136.
    Bouret SG, Draper SJ, Simerly RB. Formation of projection pathways from the arcuate nucleus of the hypothalamus to hypothalamic regions implicated in the neural control of feeding behavior in mice. J Neurosci. 2004;24(11):2797–805.PubMedCrossRefGoogle Scholar
  137. 137.
    Bouret SG, Draper SJ, Simerly RB. Trophic action of leptin on hypothalamic neurons that regulate feeding. Science. 2004;304(5667):108–10.PubMedCrossRefGoogle Scholar
  138. 138.
    Bouret SG, Simerly RB. Minireview: Leptin and development of hypothalamic feeding circuits. Endocrinology. 2004;145(6):2621–6.PubMedCrossRefGoogle Scholar
  139. 139.
    Desai M, Gayle D, Han G, Ross MG. Programmed hyperphagia due to reduced anorexigenic mechanisms in intrauterine growth-restricted offspring. Reprod Sci. 2007;14(4):329–37.PubMedCrossRefGoogle Scholar
  140. 140.
    Yura S, Itoh H, Sagawa N, Yamamoto H, Masuzaki H, Nakao K, et al. Role of premature leptin surge in obesity resulting from intrauterine undernutrition. Cell Metab. 2005;1(6):371–8.PubMedCrossRefGoogle Scholar
  141. 141.
    Vickers MH, Gluckman PD, Coveny AH, Hofman PL, Cutfield WS, Gertler A, et al. Neonatal leptin treatment reverses developmental programming. Endocrinology. 2005;146(10):4211–6.PubMedCrossRefGoogle Scholar
  142. 142.
    Desai M, Babu J, Ross MG. Programmed metabolic syndrome: prenatal undernutrition and postweaning overnutrition. Am J Physiol Regul Integr Comp Physiol. 2007;293(6):R2306–14.PubMedCrossRefGoogle Scholar
  143. 143.
    Cetin I, Morpurgo PS, Radaelli T, Taricco E, Cortelazzi D, Bellotti M, et al. Fetal plasma leptin concentrations: relationship with different intrauterine growth patterns from 19 weeks to term. Pediatr Res. 2000;48(5):646–51.PubMedCrossRefGoogle Scholar
  144. 144.
    Jaquet D, Leger J, Levy-Marchal C, Oury JF, Czernichow P. Ontogeny of leptin in human fetuses and newborns: effect of intrauterine growth retardation on serum leptin concentrations. J Clin Endocrinol Metab. 1998;83(4):1243–6.PubMedCrossRefGoogle Scholar
  145. 145.
    Matsuda J, Yokota I, Iida M, Murakami T, Yamada M, Saijo T, et al. Dynamic changes in serum leptin concentrations during the fetal and neonatal periods. Pediatr Res. 1999;45(1):71–5.PubMedCrossRefGoogle Scholar
  146. 146.
    Cinaz P, Sen E, Bideci A, Ezgu FS, Atalay Y, Koca E. Plasma leptin levels of large for gestational age and small for gestational age infants. Acta Paediatr. 1999;88(7):753–6.PubMedCrossRefGoogle Scholar
  147. 147.
    Akcurin S, Velipasaoglu S, Akcurin G, Guntekin M. Leptin profile in neonatal gonadotropin surge and relationship between leptin and body mass index in early infancy. J Pediatr Endocrinol Metab. 2005;18(2):189–95.PubMedCrossRefGoogle Scholar
  148. 148.
    Singhal A, Farooqi IS, O’Rahilly S, Cole TJ, Fewtrell M, Lucas A. Early nutrition and leptin concentrations in later life. Am J Clin Nutr. 2002;75(6):993–9.PubMedGoogle Scholar
  149. 149.
    Desai M, Li T, Ross MG. Developmental programming of dysfunctional hypothalamic neuralo stem cells in leptin deficient, low birth weight newborns. J DOHaD. 2009;1 Suppl 1:S77.Google Scholar
  150. 150.
    Wabitsch M. The acquisition of obesity: insights from cellular and genetic research. Proc Nutr Soc. 2000;59(2):325–30.PubMedCrossRefGoogle Scholar
  151. 151.
    Slavin BG. Fine structural studies on white adipocyte differentiation. Anat Rec. 1979;195(1):63–72.PubMedCrossRefGoogle Scholar
  152. 152.
    Gregoire FM, Smas CM, Sul HS. Understanding adipocyte differentiation. Physiol Rev. 1998;78(3):783–809.PubMedGoogle Scholar
  153. 153.
    Hausman DB, DiGirolamo M, Bartness TJ, Hausman GJ, Martin RJ. The biology of white adipocyte proliferation. Obes Rev. 2001;2(4):239–54.PubMedCrossRefGoogle Scholar
  154. 154.
    Poissonnet CM, Burdi AR, Bookstein FL. Growth and development of human adipose tissue during early gestation. Early Hum Dev. 1983;8(1):1–11.PubMedCrossRefGoogle Scholar
  155. 155.
    Sypniewska G, Bjorntorp P. Increased DNA synthesis in adipocytes and capillary endothelium in rat adipose tissue during overfeeding. Eur J Clin Invest. 1987;17(3):202–7.PubMedCrossRefGoogle Scholar
  156. 156.
    Adams M, Montague CT, Prins JB, Holder JC, Smith SA, Sanders L, et al. Activators of peroxisome proliferator-activated receptor gamma have depot-specific effects on human preadipocyte differentiation. J Clin Invest. 1997;100(12):3149–53.PubMedCrossRefGoogle Scholar
  157. 157.
    Gnanalingham MG, Mostyn A, Symonds ME, Stephenson T. Ontogeny and nutritional programming of adiposity in sheep: potential role of glucocorticoid action and uncoupling protein-2. Am J Physiol Regul Integr Comp Physiol. 2005;289:R1407–15.PubMedCrossRefGoogle Scholar
  158. 158.
    Symonds ME, Mostyn A, Pearce S, Budge H, Stephenson T. Endocrine and nutritional regulation of fetal adipose tissue development. J Endocrinol. 2003;179(3):293–9.PubMedCrossRefGoogle Scholar
  159. 159.
    Ailhaud G, Grimaldi P, Negrel R. Cellular and molecular aspects of adipose tissue development. Annu Rev Nutr. 1992;12:207–33.PubMedCrossRefGoogle Scholar
  160. 160.
    MacDougald OA, Lane MD. Transcriptional regulation of gene expression during adipocyte differentiation. Annu Rev Biochem. 1995;64:345–73.PubMedCrossRefGoogle Scholar
  161. 161.
    Johnson F. Sex differences in fat patterning in children and youth. In: Bouchard C, Johnson F, editors. Fat distribution during growth and later health outcomes. New York, NY: Liss; 1988. pp. 85–102.Google Scholar
  162. 162.
    Knittle JL, Timmers K, Ginsberg-Fellner F, Brown RE, Katz DP. The growth of adipose tissue in children and adolescents. Cross-sectional and longitudinal studies of adipose cell number and size. J Clin Invest. 1979;63(2):239–46.PubMedCrossRefGoogle Scholar
  163. 163.
    Gaben-Cogneville AM, Swierczewski E. Studies on cell proliferation in inguinal adipose tissue during early development in the rat. Lipids. 1979;14(7):669–75.PubMedCrossRefGoogle Scholar
  164. 164.
    Kirtland J, Harris PM. Changes in adipose tissue of the rat due early undernutrition followed by rehabilitation. 3. Changes in cell replication studied with tritiated thymidine. Br J Nutr. 1980;43(1):33–43.PubMedCrossRefGoogle Scholar
  165. 165.
    Rosen ED, Spiegelman BM. Molecular regulation of adipogenesis. Annu Rev Cell Dev Biol. 2000;16:145–71.PubMedCrossRefGoogle Scholar
  166. 166.
    Rosen ED, Spiegelman BM. PPARgamma: a nuclear regulator of metabolism, differentiation, and cell growth. J Biol Chem. 2001;276(41):37731–4.PubMedGoogle Scholar
  167. 167.
    Morrison RF, Farmer SR. Insights into the transcriptional control of adipocyte differentiation. J Cell Biochem. 1999; Suppl 32–33:75:59–67.PubMedCrossRefGoogle Scholar
  168. 168.
    Desai M, Guang H, Ferelli M, Kallichanda N, Lane RH. Programmed upregulation of adipogenic transcription factors in intrauterine growth-restricted offspring. Reprod Sci. 2008;15(8):785–96.PubMedCrossRefGoogle Scholar
  169. 169.
    Desai M, Lane RH, Han G, Ross MG. Failure to suppress adipogenic transcription factor (PPAR) activity leads to programmed obesity in IUGR offspring. Reprod Sci. 2008;15 Suppl:76A.CrossRefGoogle Scholar
  170. 170.
    Powell E, Kuhn P, Xu W. Nuclear receptor cofactors in PPARgamma-mediated adipogenesis and adipocyte energy metabolism. PPAR Res. 2006;2007:53843.Google Scholar
  171. 171.
    Yang T, Fu M, Pestell R, Sauve AA. SIRT1 and endocrine signaling. Trends Endocrinol Metab. 2006;17(5):186–91.PubMedCrossRefGoogle Scholar
  172. 172.
    Picard F, Kurtev M, Chung N, Topark-Ngarm A, Senawong T, hado De OR, et al. Sirt1 promotes fat mobilization in white adipocytes by repressing PPAR-gamma. Nature. 2004;429(6993):771–6.PubMedCrossRefGoogle Scholar
  173. 173.
    Kloting N, Bluher M. Extended longevity and insulin signaling in adipose tissue. Exp Gerontol. 2005;40(11):878–83.PubMedCrossRefGoogle Scholar
  174. 174.
    Walczak R, Tontonoz P. PPARadigms and PPARadoxes: expanding roles for PPARgamma in the control of lipid metabolism. J Lipid Res. 2002;43(2):177–86.PubMedGoogle Scholar
  175. 175.
    Bocher V, Pineda-Torra I, Fruchart JC, Staels B. PPARs: transcription factors controlling lipid and lipoprotein metabolism. Ann N Y Acad Sci. 2002;967:7–18.PubMedCrossRefGoogle Scholar
  176. 176.
    Schoonjans K, Staels B, Auwerx J. The peroxisome proliferator activated receptors (PPARS) and their effects on lipid metabolism and adipocyte differentiation. Biochim Biophys Acta. 1996;1302(2):93–109.PubMedCrossRefGoogle Scholar
  177. 177.
    Kim JB, Spiegelman BM. ADD1/SREBP1 promotes adipocyte differentiation and gene expression linked to fatty acid metabolism. Genes Dev. 1996;10(9):1096–107.PubMedCrossRefGoogle Scholar
  178. 178.
    Ailhaud G, Amri EZ, Grimaldi PA. Fatty acids and adipose cell differentiation. Prostaglandins Leukot Essent Fatty Acids. 1995;52(2–3):113–5.PubMedCrossRefGoogle Scholar
  179. 179.
    Schoonjans K, Peinado-Onsurbe J, Lefebvre AM, Heyman RA, Briggs M, Deeb S, et al. PPARalpha and PPARgamma activators direct a distinct tissue-specific transcriptional response via a PPRE in the lipoprotein lipase gene. EMBO J. 1996;15(19):5336–48.PubMedGoogle Scholar
  180. 180.
    Kim JB, Sarraf P, Wright M, Yao KM, Mueller E, Solanes G, et al. Nutritional and insulin regulation of fatty acid synthetase and leptin gene expression through ADD1/SREBP1. J Clin Invest. 1998;101(1):1–9.PubMedCrossRefGoogle Scholar
  181. 181.
    Boizard M, Le LX, Lemarchand P, Foufelle F, Ferre P, Dugail I. Obesity-related overexpression of fatty-acid synthase gene in adipose tissue involves sterol regulatory element-binding protein transcription factors. J Biol Chem. 1998;273(44):29164–71.PubMedCrossRefGoogle Scholar
  182. 182.
    Desai M, Lane RH, Han G, Ross MG. Response of IUGR primary cell culture adipocytes to PPARg activator-ligand and repressor-ligand mechanisms of programmed obesity. Reprod Sci. 2008;15 Suppl:194A.CrossRefGoogle Scholar
  183. 183.
    Fowden AL, Giussani DA, Forhead AJ. Endocrine and metabolic programming during intrauterine development. Early Hum Dev. 2005;81(9):723–34.PubMedCrossRefGoogle Scholar
  184. 184.
    Phillips DI. Fetal programming of the neuroendocrine response to stress: links between low birth weight and the metabolic syndrome. Endocr Res. 2004;30(4):819–26.PubMedCrossRefGoogle Scholar
  185. 185.
    Lesage J, Blondeau B, Grino M, Breant B, Dupouy JP. Maternal undernutrition during late gestation induces fetal overexposure to glucocorticoids and intrauterine growth retardation, and disturbs the hypothalamo-pituitary adrenal axis in the newborn rat. Endocrinology. 2001;142(5):1692–702.PubMedCrossRefGoogle Scholar
  186. 186.
    Benediktsson R, Lindsay RS, Noble J, Seckl JR, Edwards CR. Glucocorticoid exposure in utero: new model for adult hypertension. Lancet. 1993;341(8841):339–41.PubMedCrossRefGoogle Scholar
  187. 187.
    O’Regan D, Kenyon CJ, Seckl JR, Holmes MC. Glucocorticoid exposure in late gestation in the rat permanently programs gender-specific differences in adult cardiovascular and metabolic physiology. Am J Physiol Endocrinol Metab. 2004;287(5):E863–E70.PubMedCrossRefGoogle Scholar
  188. 188.
    Murphy BE, Clark SJ, Donald IR, Pinsky M, Vedady D. Conversion of maternal cortisol to cortisone during placental transfer to the human fetus. Am J Obstet Gynecol. 1974;118(4):538–41.PubMedGoogle Scholar
  189. 189.
    Brown RW, Chapman KE, Kotelevtsev Y, Yau JL, Lindsay RS, Brett L, et al. Cloning and production of antisera to human placental 11 beta-hydroxysteroid dehydrogenase type 2. Biochem J. 1996;313(Pt 3):1007–17.PubMedGoogle Scholar
  190. 190.
    Stewart PM, Rogerson FM, Mason JI. Type 2 11 beta-hydroxysteroid dehydrogenase messenger ribonucleic acid and activity in human placenta and fetal membranes: its relationship to birth weight and putative role in fetal adrenal steroidogenesis. J Clin Endocrinol Metab. 1995;80(3):885–90.PubMedCrossRefGoogle Scholar
  191. 191.
    Symonds ME, Budge H, Stephenson T, Gardner DS. Leptin, fetal nutrition, and long-term outcomes for adult hypertension. Endothelium. 2005;12(1–2):73–9.PubMedCrossRefGoogle Scholar
  192. 192.
    Rajala MW, Scherer PE. Minireview: The adipocyte – at the crossroads of energy homeostasis, inflammation, and atherosclerosis. Endocrinology. 2003;144(9):3765–73.PubMedCrossRefGoogle Scholar
  193. 193.
    Shepherd PR, Crowther NJ, Desai M, Hales CN, Ozanne SE. Altered adipocyte properties in the offspring of protein malnourished rats. Br J Nutr. 1997;78(1):121–9.PubMedCrossRefGoogle Scholar
  194. 194.
    Kubota N, Terauchi Y, Miki H, Tamemoto H, Yamauchi T, Komeda K, et al. PPAR gamma mediates high-fat diet-induced adipocyte hypertrophy and insulin resistance. Mol Cell. 1999;4(4):597–609.PubMedCrossRefGoogle Scholar
  195. 195.
    Bluher M, Michael MD, Peroni OD, Ueki K, Carter N, Kahn BB, et al. Adipose tissue selective insulin receptor knockout protects against obesity and obesity-related glucose intolerance. Dev Cell. 2002;3(1):25–38.PubMedCrossRefGoogle Scholar
  196. 196.
    Hara K, Kubota N, Tobe K, Terauchi Y, Miki H, Komeda K, et al. The role of PPARgamma as a thrifty gene both in mice and humans. Br J Nutr. 2000;84 Suppl 2:S235–9.PubMedCrossRefGoogle Scholar
  197. 197.
    Kadowaki T, Hara K, Kubota N, Tobe K, Terauchi Y, Yamauchi T, et al. The role of PPARgamma in high-fat diet-induced obesity and insulin resistance. J Diabetes Complications. 2002;16(1):41–5.PubMedCrossRefGoogle Scholar
  198. 198.
    Passos MC, Vicente LL, Lisboa PC, de Moura EG. Absence of anorectic effect to acute peripheral leptin treatment in adult rats whose mothers were malnourished during lactation. Horm Metab Res. 2004;36(9):625–9.PubMedCrossRefGoogle Scholar
  199. 199.
    Djiane J, Attig L. Role of leptin during perinatal metabolic programming and obesity. J Physiol Pharmacol. 2008;59 Suppl 1:55–63.PubMedGoogle Scholar
  200. 200.
    Melnik BC. Milk–the promoter of chronic Western diseases. Med Hypotheses. 2009;72(6):631–9.PubMedCrossRefGoogle Scholar
  201. 201.
    Vickers MH. Developmental programming and adult obesity: the role of leptin. Curr Opin Endocrinol Diabetes Obes. 2007;14(1):17–22.PubMedCrossRefGoogle Scholar
  202. 202.
    Ukkola O. Ghrelin and metabolic disorders. Curr Protein Pept Sci. 2009;10(1):2–7.PubMedCrossRefGoogle Scholar
  203. 203.
    Hammond RA. Complex systems modeling for obesity research. Prev Chronic Dis. 2009;6(3):A97.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2011

Authors and Affiliations

  1. 1.Department of Obstetrics and GynecologyHarbor-UCLA Medical CenterTorranceUSA
  2. 2.Department of Obstetrics and GynecologyDavid Geffen School of Medicine at Harbor-UCLA Medical SchoolTorranceUSA

Personalised recommendations